Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mproand cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19
- Resource Type
- Article
- Authors
- Mao, Long; Shaabani, Namir; Zhang, Xiaoying; Jin, Can; Xu, Wanhong; Argent, Christopher; Kushnareva, Yulia; Powers, Colin; Stegman, Karen; Liu, Jia; Xie, Hui; Xu, Changxu; Bao, Yimei; Xu, Lijun; Zhang, Yuren; Yang, Haigang; Qian, Shengdian; Hu, Yong; Shao, Jianping; Zhang, Can; Li, Tingting; Li, Yi; Liu, Na; Lin, Zhenhao; Wang, Shanbo; Wang, Chao; Shen, Wei; Lin, Yuanlong; Shu, Dan; Zhu, Zhenhong; Kotoi, Olivia; Kerwin, Lisa; Han, Qing; Chumakova, Ludmila; Teijaro, John; Royal, Mike; Brunswick, Mark; Allen, Robert; Ji, Henry; Lu, Hongzhou; Xu, Xiao
- Source
- Med; February 2024, Vol. 5 Issue: 2 p169-171, 3p
- Subject
- Language
- ISSN
- 26666340